Carregant...
CD34 is not Expressed by Blasts in a Third of B-ALL Patients and Its Negativity is associated with Aberrant Marker Expression: A Retrospective Analysis
BACKGROUND: CD34 antigen is expressed by early hematopoietic progenitor cells and acute leukemia cells. Its expression is associated with good prognosis in acute myeloid leukemia. Literature is sparse on its prognostic significance in B- acute lymphoblastic leukemia (B-ALL) especially from India. He...
Guardat en:
| Publicat a: | Asian Pac J Cancer Prev |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
West Asia Organization for Cancer Prevention
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8286681/ https://ncbi.nlm.nih.gov/pubmed/33773558 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.31557/APJCP.2021.22.3.919 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|